The chemical class termed BDP1 Activators encompasses a range of compounds that, through various mechanisms, can enhance the expression of the BDP1 protein, a key component of the transcription factor complex TFIIIB. These activators are not a homogenous group but are instead classified based on their ability to modulate the intricate process of gene expression. Some of these chemicals act at the genetic level, altering the epigenetic landscape, such as histone acetylation or DNA methylation, to promote the transcription of the BDP1 gene. Others exert their effects indirectly by engaging with cellular signaling pathways that govern transcriptional machinery activity. For instance, activators that increase intracellular cAMP levels may lead to a cascade of events culminating in the upregulation of BDP1. The precise mechanisms by which these activators function can vary widely, with some directly interacting with DNA or transcription factors, while others modulate the activity of enzymes that control the accessibility of chromatin or the stability of mRNA.
The study of BDP1 Activators provides valuable insights into the regulation of RNA Polymerase III and its associated transcriptional processes. These molecules can serve as critical tools for probing the fundamental aspects of gene expression and the maintenance of cellular homeostasis. By influencing the expression of BDP1, these activators contribute to the understanding of how transcription factors assemble and how the transcription initiation complex is stabilized and made more efficient. The compounds range from naturally occurring substances, like certain vitamins and phytochemicals, which might engage with cellular receptors, to synthetic molecules designed to target specific molecular pathways. Whether through direct or indirect means, the actions of BDP1 Activators shed light on the dynamic nature of transcriptional control and the elaborate network of interactions that facilitate the synthesis of essential proteins within the cell.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This DNA methyltransferase inhibitor could hypothetically upregulate BDP1 by causing hypomethylation of its gene promoter, leading to increased transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As an HDAC inhibitor, it might increase the acetylation of histones around the BDP1 gene, resulting in a more open chromatin structure and potentially higher gene expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
It might modulate BDP1 expression through retinoic acid receptors, which can act as transcription factors binding to the regulatory regions of various genes. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
By activating adenylyl cyclase and increasing cAMP, Forskolin could potentially enhance BDP1 expression by cAMP response element-binding protein (CREB) mediated transcription. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This polyphenol might exert epigenetic effects that could hypothetically affect BDP1 gene expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
As an HDAC inhibitor, it could potentially induce histone hyperacetylation and enhance transcription of BDP1. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Through inhibition of GSK-3β, it might influence Wnt signaling, potentially affecting BDP1 expression indirectly. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor like Rapamycin might alter the translation and degradation of proteins, which could potentially affect BDP1 levels. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
This compound might influence BDP1 expression through its effects on SIRT1 and other signaling pathways. | ||||||
Metformin-d6, Hydrochloride | 1185166-01-1 | sc-218701 sc-218701A sc-218701B | 1 mg 5 mg 10 mg | $292.00 $822.00 $1540.00 | 1 | |
Metformin might affect BDP1 expression through AMPK activation and subsequent transcriptional regulation. | ||||||